Back
Daiichi Sankyo Vs. Nxera Pharma Industry Stock Comparison
Sell
39
DSNKY
Daiichi Sankyo
Last Price:
30.18
Seasonality Move:
4.05%
Sell
29
SOLTF
Nxera Pharma
Last Price:
9.72
Seasonality Move:
-3.15%
Sell
39
Daiichi Sankyo (DSNKY)
is a Sell
Is Daiichi Sankyo a Buy, Sell or Hold?
- The current Daiichi Sankyo [DSNKY] share price is $30.18. The Score for DSNKY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- DSNKY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.72. The Score for SOLTF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSNKY Stock Price Chart
What is Daiichi Sankyo's stock price today?
-
The Daiichi Sankyo share price today is $30.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DSNKY is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
DSNKY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 44.74 | Sell |
| Chaikin Money Flow: | 13919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.83 - 32.41) | Sell |
| Bollinger Bands (100): | (28.09 - 32.33) | Sell |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 38.47 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10 - 10.68) | Sell |
| Bollinger Bands (100): | (9.28 - 10.82) | Sell |
DSNKY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 30.71 | Sell |
| 50-day SMA: | 31.85 | Sell |
| 200-day SMA: | 29.12 | Buy |
| 8-day EMA: | 29.85 | Buy |
| 20-day EMA: | 30.52 | Sell |
| 50-day EMA: | 30.96 | Sell |
| 200-day EMA: | 30.15 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.08 | Sell |
| 20-day SMA: | 10.29 | Sell |
| 50-day SMA: | 10.05 | Sell |
| 200-day SMA: | 10.34 | Sell |
| 8-day EMA: | 9.97 | Sell |
| 20-day EMA: | 10.18 | Sell |
| 50-day EMA: | 10.18 | Sell |
| 200-day EMA: | 11.02 | Sell |
Daiichi Sankyo Earnings Growth & DSNKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Daiichi Sankyo Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||